Literature DB >> 14392118

Prevalence of antibody to Pseudomonas in normal human sera.

S GAINES, M LANDY.   

Abstract

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; PSEUDOMONAS AERUGINOSA/immunology

Mesh:

Substances:

Year:  1955        PMID: 14392118      PMCID: PMC357601          DOI: 10.1128/jb.69.6.628-633.1955

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  3 in total

1.  On hemagglutination procedures utilizing isolated polysaccharide and protein antigens.

Authors:  M LANDY
Journal:  Am J Public Health Nations Health       Date:  1954-08

2.  Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen.

Authors:  M LANDY; E LAMB
Journal:  Proc Soc Exp Biol Med       Date:  1953-04

3.  Pseudomonas aeruginosa: Its Rôle as a Plant Pathogen.

Authors:  R P Elrod; A C Braun
Journal:  J Bacteriol       Date:  1942-12       Impact factor: 3.490

  3 in total
  19 in total

1.  EVALUATION OF ANTIBIOTIC PROPHYLAXIS AND GAMMA-GLOBULIN, PLASMA, ALBUMIN AND SALINE-SOLUTION THERAPY IN SEVERE BURNS. BACTERIOLOGIC AND IMMUNOLOGIC STUDIES.

Authors:  N A KEFALIDES; J A ARANA; A BAZAN; N VELARDE; S M ROSENTHAL
Journal:  Ann Surg       Date:  1964-04       Impact factor: 12.969

2.  GROWTH, TOXIGENICITY AND VIRULENCE OF PSEUDOMONAS AERUGINOSA.

Authors:  P V LIU; C B MERCER
Journal:  J Hyg (Lond)       Date:  1963-12

3.  Study on antibodies against enteric pathogens in human gamma globulin.

Authors:  E NETER; A M DRISLANE; A H HARRIS; E A GORZYNSKI
Journal:  Am J Public Health Nations Health       Date:  1959-08

4.  Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.

Authors:  J E Pennington; G J Small; M E Lostrom; G B Pier
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

5.  Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.

Authors:  J A Bass; J C McCoy
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

6.  Bactericidal method for the measurement in normal serum of antibody to gramnegative bacteria.

Authors:  M LANDY; J G MICHAEL; J L WHITBY
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

7.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.

Authors:  R J Jones; E A Roe
Journal:  Br J Exp Pathol       Date:  1975-02

10.  Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.

Authors:  R M Guttman; B A Waisbren
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.